OXiGENE Biotech Specialty Pharma

701 Gateway Blvd, Suite 210

South San Francisco, CA 94080 USA Phone Fax

Click for website

Research Sector Biotech Specialty Pharma

Summary Description Therapeutics: Cancer, sight-threatening illnesses

Management David J. Chaplin, Ph.D., President and Chief Executive Officer; Barbara Riching, CPA, Chief Financial Officer; Jai Balkissoon, M.D., Senior Clinical Research Consultant; Kathleen M. Lee, MBA, Ph.D., Vice President, CMC (Chemistry, Manufacturing and Controls); Alice M. Varga, MS, MA, Vice President, Regulatory and Quality Assurance; Ravi Kaiwar, MBA, Ph.D., Business Development Consultant

Click here for Financial Data Keywords: fosbretabulin, anaplastic, randomized, chemotherapeutic, bevacizumab, cancer, oncology, ovarian cancer, ophthalmology